Improving vaccine effectiveness monitoring for respiratory and gastrointestinal illnesses in children
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases
This study is looking at how well vaccines for illnesses like the flu and COVID-19 work to protect young children from serious respiratory and stomach infections, so we can make sure they stay healthy and safe.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11046457 on NIH RePORTER |
What this research studies
This research focuses on enhancing surveillance for acute respiratory illness (ARI) and acute gastroenteritis (AGE), which are major causes of death in young children. It aims to monitor the effectiveness of vaccines against these illnesses, particularly influenza and SARS-CoV-2, by assessing disease burden, causative pathogens, and vaccine impact. The study will involve rigorous, prospective data collection to understand how well vaccines protect children and to inform public health strategies. By tracking changes in pathogens and vaccine effectiveness over time, the research seeks to improve vaccination strategies and outcomes for pediatric populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are young children, particularly those who are at risk for ARI and AGE, including those eligible for influenza and SARS-CoV-2 vaccinations.
Not a fit: Patients who are not children or those who have already been vaccinated against the specific pathogens being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccine strategies that significantly reduce the incidence of severe respiratory and gastrointestinal diseases in children.
How similar studies have performed: Previous research has shown success in monitoring vaccine effectiveness for influenza and other diseases, indicating that this approach is both relevant and necessary.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Halasa, Natasha Bassam — Vanderbilt University Medical Center
- Study coordinator: Halasa, Natasha Bassam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.